AHA today urged the Antitrust Division of the Department of Justice to investigate thoroughly Centene's proposed acquisition of WellCare “because it threatens to reduce competition in delivery of Medicaid managed care and Medicare Advantage services to tens of millions of consumers across broad swaths of the country.” The letter notes, “There is no service more important to American consumers than health care, and vigorous competition among health insurance companies is necessary to ensure that consumers receive high quality at affordable rates. The facts show that the WellCare-Centene transaction is likely to significantly reduce competition and will therefore harm the most vulnerable Americans. DOJ should vigorously review this transaction's effects on current and future competition and take all appropriate measures to protect U.S. consumers.”

Related News Articles

Headline
The top three large-group insurers control an average of 82.2% of the market share in each state, nearly twice the combined average market share of each state’…
Headline
The International Hospital Federation has extended the nomination deadline to May 3 for its 2024 awards honoring excellence in hospitals and health care…
Headline
During its Annual Membership Meeting April 14 in Washington, D.C., the AHA honored 2024 Board Chair Joanne Conroy, M.D., president and CEO of Dartmouth Health…
Headline
On April 15 at the AHA Annual Membership Meeting in Washington, D.C., AHA will present Nancy Howell Agee, CEO of Carilion Clinic, and Brian Gragnolati,…
Headline
The Environmental Protection Agency March 26 presented AHA’s American Society for Health Care Engineering with a 2024 ENERGY STAR Partner of the Year —…
Headline
Jill Howard, R.N., senior consultant, Sheppard Pratt Solutions, is the 2024 chair of AHA’s Committee on Behavioral Health. Zelia Baugh, executive vice…